Avalo Therapeutics Inc
XNAS: AVTX
Avalo Therapeutics Inc Live Stock Price Today, Share Analysis and Chart
about
Avalo Therapeutics Inc is a clinical-stage biotechnology company focused on the treatment of immune dysregulation. The company's asset is AVTX-009, an anti-IL-1B monoclonal antibody ("mAb"), targeting inflammatory diseases. Avalo's pipeline also incl...
Read More
13.10
0.39
(3.07%)
164.8K
XNAS Volume
High vol.+gain this week
XNAS 01 Oct, 2025 10:51 AM (EDT)
Not Eligible
Expensive Valuation
Technically Bullish
Avalo Therapeutics Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..